Glucocorticoids are associated with increased risk of bone loss and fracture. This study
compared the prescribing of bone protective agents by rheumatologists in clinical practice …

Background: Patients treated with steroids are at risk of glucocorticoid-induced osteoporosis.
Appropriate investigations and therapeutic agents can decrease rate of bone loss and …

Glucocorticoids, prescribed for their antiinflammatory and immunosuppressive features, are
the most common cause of secondary osteoporosis. Used to treat a variety of diseases …

Osteoporosis is a common and serious complication of glucocorticoid therapy. Recent
advances in the epidemiology, pathophysiology, and management of glucocorticoid …

OBJECTIVE: To determine longitudinal patterns and predictors for the utilization of bone
mass measurements and anti-osteoporotic medications in the prevention of glucocorticoid …

Background: The burden of osteoporosis is on the rise and glucocorticoids are one of the
leading causes of drug‐induced osteoporosis. According to available guidelines, patients on …

Systemically administered glucocorticoids are widely used in rheumatology and have many
serious side effects. Approximately 30–50% of patients chronically taking glucocorticoids …

Glucocorticoids are a potent cause of osteoporosis and thus a potential source of substantial
morbidity in patients who are already significantly disabled by their underlying condition …

Objective To evaluate patient and physician factors associated with prevention of
glucocorticoid‐induced osteoporosis and to describe temporal trends in screening and …

Glucocorticosteroid-induced osteoporosis (GIO) is the most common cause of secondary
osteoporosis but is underdiagnosed and undertreated [1]. Most professional guidelines [2, 3] …